Acelyrin Inc (SLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SLRN | GLSI | CGEN | ||
| Company | Acelyrin Inc | Greenwich Lifesciences Inc | Compugen Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.24 | 18.56 | 2.30 | ||
| High | 2.36 | 18.96 | 2.38 | ||
| Low | 2.20 | 15.55 | 2.27 | ||
| Latest | 2.27 | 16.32 | 2.37 | ||
| Change | +0.04 | -2.69 | +0.04 | ||
| % Change | +1.79% | -14.15% | +1.72% | ||
| Volume | 4,076,500 | 333,800 | 154,800 | ||
| 20-Day Average Volume | 1,091,300 | 161,535 | 277,835 | ||
| Previous Close | 2.23 | 19.01 | 2.33 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.33 | 20.60 | 2.23 | ||
| 20-Day Raw Stochastic | 45.16% | 8.24% | 68.33% | ||
| 20-Day Relative Strength | 47.29 | 36.80 | 52.76 | ||
| Weighted Alpha | -28.45 | -19.15 | +44.66 | ||
| Today's Opinion | 88% Sell | 56% Sell | 40% Buy | ||
| Previous Opinion | 88% Sell | 56% Sell | 40% Buy | ||
| Last Month's Opinion | 100% Sell | 8% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.61% since 05/13/25 | -17.58% since 07/10/26 | -0.84% since 07/10/26 | ||
| Low | 1.95 on 05/15/25 | 15.55 on 07/17/26 | 2.22 on 07/14/26 | ||
| High | 2.36 on 05/20/25 | 21.70 on 07/16/26 | 2.43 on 07/15/26 | ||
| 1-Month | |||||
| %Chg | +3.18% since 04/17/25 | -31.97% since 06/17/26 | +19.10% since 06/17/26 | ||
| Low | 1.95 on 05/15/25 | 15.55 on 07/17/26 | 1.96 on 06/18/26 | ||
| High | 2.65 on 05/01/25 | 24.90 on 06/18/26 | 2.56 on 07/09/26 | ||
| 3-Month | |||||
| %Chg | +4.61% since 02/20/25 | -41.17% since 04/17/26 | -15.96% since 04/17/26 | ||
| Low | 1.95 on 05/15/25 | 15.55 on 07/17/26 | 1.95 on 06/10/26 | ||
| High | 2.94 on 04/02/25 | 29.93 on 06/01/26 | 3.23 on 04/24/26 | ||
| 6-Month | |||||
| %Chg | -48.76% since 11/20/24 | -34.41% since 01/16/26 | +0.42% since 01/16/26 | ||
| Low | 1.85 on 02/11/25 | 15.55 on 07/17/26 | 1.58 on 02/05/26 | ||
| High | 5.03 on 11/25/24 | 34.10 on 01/27/26 | 3.23 on 04/24/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 229,166 | 239,545 | 224,091 | ||
| Shares Outstanding, K | 100,954 | 14,678 | 94,553 | ||
| Annual Sales | 0 | 0 | 72,760,000 | ||
| Annual Net Income | -248,230,000 | -19,360,000 | 35,340,000 | ||
| Last Quarter Sales | 0 | 0 | 2,180,000 | ||
| Last Quarter Net Income | -55,260,000 | -5,660,000 | -7,670,000 | ||
| 60-Month Beta | 1.07 | 1.40 | 2.76 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.55 on 05/14/25 | -0.39 on 06/03/26 | -0.08 on 05/18/26 | ||
| Earnings Date | 08/12/25 | 08/13/26 | 08/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 6.30 | ||